{"entity":{"type":"insider","cik":"0001630299","url":"/insider/0001630299","json_url":"/insider/0001630299.json","name":"O'Neill Julie","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":32,"n_filings":16,"first":"2015-02-12","last":"2026-08-12","span_basis":"filed_date"},"name_variants":[{"name":"O'Neill Julie","source":"filing","n_filings":16,"first_seen":"2015-02-12","last_seen":"2026-08-12"}],"transactions":[{"id":9293664,"accession":"0001628280-26-056327","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-26-056327","line_url":"/filing/0001628280-26-056327","is_derivative":false,"issuer_cik":"0001060955","issuer_name":"ICON PLC","issuer_ticker":"ICLR","issuer_name_source":null,"issuer_url":"/issuer/0001060955","owner_cik":"0001630299","owner_name":"O'Neill Julie","owner_display_name":"O'Neill Julie","owner_url":"/insider/0001630299","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":915.0,"shares_display":"915","price_per_share":164.29095081967213,"price_display":"164.29","price_state":"stated","total_value":150326.22,"total_display":"150,326.22","total_whole":"150,326","shares_owned_after":4230.0,"shares_owned_after_display":"4,230","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-11","filed_date":"2026-08-12","scope":"insider","n_lines":4},{"id":6745392,"accession":"0000899866-18-000048","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899866-18-000048","line_url":"/filing/0000899866-18-000048#line-2","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001630299","owner_name":"O'Neill Julie","owner_display_name":"O'Neill Julie","owner_url":"/insider/0001630299","role":"Officer (EVP. Global Operations)","role_mark":"O","role_mark_label":"Officer (EVP. Global Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP. Global Operations","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":686.0,"shares_display":"686","price_per_share":118.61,"price_display":"118.61","price_state":"stated","total_value":81366.46,"total_display":"81,366.46","total_whole":"81,366","shares_owned_after":42787.0,"shares_owned_after_display":"42,787","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-28","filed_date":"2018-03-01","scope":"insider"},{"id":6745388,"accession":"0000899866-18-000048","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-18-000048","line_url":"/filing/0000899866-18-000048#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001630299","owner_name":"O'Neill Julie","owner_display_name":"O'Neill Julie","owner_url":"/insider/0001630299","role":"Officer (EVP. Global Operations)","role_mark":"O","role_mark_label":"Officer (EVP. Global Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP. Global Operations","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":939.0,"shares_display":"939","price_per_share":120.72,"price_display":"120.72","price_state":"stated","total_value":113356.08,"total_display":"113,356.08","total_whole":"113,356","shares_owned_after":43473.0,"shares_owned_after_display":"43,473","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-27","filed_date":"2018-03-01","scope":"insider"},{"id":6217759,"accession":"0000899866-18-000038","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899866-18-000038","line_url":"/filing/0000899866-18-000038#line-3","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001630299","owner_name":"O'Neill Julie","owner_display_name":"O'Neill Julie","owner_url":"/insider/0001630299","role":"Officer (EVP. Global Operations)","role_mark":"O","role_mark_label":"Officer (EVP. Global Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP. Global Operations","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4787.0,"shares_display":"4,787","price_per_share":116.31,"price_display":"116.31","price_state":"stated","total_value":556775.97,"total_display":"556,775.97","total_whole":"556,776","shares_owned_after":44412.0,"shares_owned_after_display":"44,412","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-08","filed_date":"2018-02-08","scope":"insider"},{"id":6114185,"accession":"0000899866-18-000014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-18-000014","line_url":"/filing/0000899866-18-000014#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001630299","owner_name":"O'Neill Julie","owner_display_name":"O'Neill Julie","owner_url":"/insider/0001630299","role":"Officer (EVP. Global Operations)","role_mark":"O","role_mark_label":"Officer (EVP. Global Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP. Global Operations","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2119.0,"shares_display":"2,119","price_per_share":117.26,"price_display":"117.26","price_state":"stated","total_value":248473.94,"total_display":"248,473.94","total_whole":"248,474","shares_owned_after":20210.0,"shares_owned_after_display":"20,210","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-05","filed_date":"2018-02-07","scope":"insider"},{"id":4440086,"accession":"0000899866-17-000161","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899866-17-000161","line_url":"/filing/0000899866-17-000161","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001630299","owner_name":"O'Neill Julie","owner_display_name":"O'Neill Julie","owner_url":"/insider/0001630299","role":"Officer (EVP. Global Operations)","role_mark":"O","role_mark_label":"Officer (EVP. Global Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP. Global Operations","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3763.0,"shares_display":"3,763","price_per_share":145.99540526175923,"price_display":"146.00","price_state":"stated","total_value":549380.71,"total_display":"549,380.71","total_whole":"549,381","shares_owned_after":24251.0,"shares_owned_after_display":"24,251","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-05","filed_date":"2017-09-05","scope":"insider","n_lines":4},{"id":4440058,"accession":"0000899866-17-000161","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-17-000161","line_url":"/filing/0000899866-17-000161#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001630299","owner_name":"O'Neill Julie","owner_display_name":"O'Neill Julie","owner_url":"/insider/0001630299","role":"Officer (EVP. Global Operations)","role_mark":"O","role_mark_label":"Officer (EVP. Global Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP. Global Operations","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":612.0,"shares_display":"612","price_per_share":142.0,"price_display":"142.00","price_state":"stated","total_value":86904.0,"total_display":"86,904.00","total_whole":"86,904","shares_owned_after":26092.0,"shares_owned_after_display":"26,092","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-31","filed_date":"2017-09-05","scope":"insider"},{"id":5052314,"accession":"0000899866-17-000157","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-17-000157","line_url":"/filing/0000899866-17-000157#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001630299","owner_name":"O'Neill Julie","owner_display_name":"O'Neill Julie","owner_url":"/insider/0001630299","role":"Officer (EVP. Global Operations)","role_mark":"O","role_mark_label":"Officer (EVP. Global Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP. Global Operations","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11160.0,"shares_display":"11,160","price_per_share":140.0,"price_display":"140.00","price_state":"stated","total_value":1562400.0,"total_display":"1,562,400.00","total_whole":"1,562,400","shares_owned_after":26704.0,"shares_owned_after_display":"26,704","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-28","filed_date":"2017-08-30","scope":"insider"},{"id":4734367,"accession":"0000899866-17-000066","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-17-000066","line_url":"/filing/0000899866-17-000066#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001630299","owner_name":"O'Neill Julie","owner_display_name":"O'Neill Julie","owner_url":"/insider/0001630299","role":"Officer (EVP. Global Operations)","role_mark":"O","role_mark_label":"Officer (EVP. Global Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP. Global Operations","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":651.0,"shares_display":"651","price_per_share":133.8,"price_display":"133.80","price_state":"stated","total_value":87103.8,"total_display":"87,103.80","total_whole":"87,104","shares_owned_after":37864.0,"shares_owned_after_display":"37,864","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-02","filed_date":"2017-03-06","scope":"insider"},{"id":4440054,"accession":"0000899866-17-000059","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899866-17-000059","line_url":"/filing/0000899866-17-000059#line-3","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001630299","owner_name":"O'Neill Julie","owner_display_name":"O'Neill Julie","owner_url":"/insider/0001630299","role":"Officer (EVP. Global Operations)","role_mark":"O","role_mark_label":"Officer (EVP. Global Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP. Global Operations","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":664.0,"shares_display":"664","price_per_share":131.7,"price_display":"131.70","price_state":"stated","total_value":87448.8,"total_display":"87,448.80","total_whole":"87,449","shares_owned_after":31015.0,"shares_owned_after_display":"31,015","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-28","filed_date":"2017-03-01","scope":"insider"},{"id":4440042,"accession":"0000899866-17-000059","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-17-000059","line_url":"/filing/0000899866-17-000059#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001630299","owner_name":"O'Neill Julie","owner_display_name":"O'Neill Julie","owner_url":"/insider/0001630299","role":"Officer (EVP. Global Operations)","role_mark":"O","role_mark_label":"Officer (EVP. Global Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP. Global Operations","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":910.0,"shares_display":"910","price_per_share":131.2,"price_display":"131.20","price_state":"stated","total_value":119392.0,"total_display":"119,392.00","total_whole":"119,392","shares_owned_after":31679.0,"shares_owned_after_display":"31,679","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-27","filed_date":"2017-03-01","scope":"insider"},{"id":4257188,"accession":"0000899866-17-000030","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-17-000030","line_url":"/filing/0000899866-17-000030#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001630299","owner_name":"O'Neill Julie","owner_display_name":"O'Neill Julie","owner_url":"/insider/0001630299","role":"Officer (EVP. Global Operations)","role_mark":"O","role_mark_label":"Officer (EVP. Global Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP. Global Operations","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2795.0,"shares_display":"2,795","price_per_share":125.69,"price_display":"125.69","price_state":"stated","total_value":351303.55,"total_display":"351,303.55","total_whole":"351,304","shares_owned_after":32589.0,"shares_owned_after_display":"32,589","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-06","filed_date":"2017-02-08","scope":"insider"},{"id":2943236,"accession":"0000899866-16-000349","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-16-000349","line_url":"/filing/0000899866-16-000349#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001630299","owner_name":"O'Neill Julie","owner_display_name":"O'Neill Julie","owner_url":"/insider/0001630299","role":"Officer (EVP. Global Operations)","role_mark":"O","role_mark_label":"Officer (EVP. Global Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP. Global Operations","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":650.0,"shares_display":"650","price_per_share":126.29,"price_display":"126.29","price_state":"stated","total_value":82088.5,"total_display":"82,088.50","total_whole":"82,089","shares_owned_after":35384.0,"shares_owned_after_display":"35,384","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-02","filed_date":"2016-09-02","scope":"insider"},{"id":3032963,"accession":"0000899866-16-000278","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-16-000278","line_url":"/filing/0000899866-16-000278#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001630299","owner_name":"O'Neill Julie","owner_display_name":"O'Neill Julie","owner_url":"/insider/0001630299","role":"Officer (EVP. Global Operations)","role_mark":"O","role_mark_label":"Officer (EVP. Global Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP. Global Operations","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":651.0,"shares_display":"651","price_per_share":149.55,"price_display":"149.55","price_state":"stated","total_value":97357.05,"total_display":"97,357.05","total_whole":"97,357","shares_owned_after":36034.0,"shares_owned_after_display":"36,034","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-02","filed_date":"2016-03-04","scope":"insider"},{"id":3069916,"accession":"0000899866-16-000268","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899866-16-000268","line_url":"/filing/0000899866-16-000268#line-2","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001630299","owner_name":"O'Neill Julie","owner_display_name":"O'Neill Julie","owner_url":"/insider/0001630299","role":"Officer (EVP. Global Operations)","role_mark":"O","role_mark_label":"Officer (EVP. Global Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP. Global Operations","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":663.0,"shares_display":"663","price_per_share":138.91,"price_display":"138.91","price_state":"stated","total_value":92097.33,"total_display":"92,097.33","total_whole":"92,097","shares_owned_after":36685.0,"shares_owned_after_display":"36,685","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-29","filed_date":"2016-03-01","scope":"insider"},{"id":2235629,"accession":"0000899866-16-000238","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000899866-16-000238","line_url":"/filing/0000899866-16-000238","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001630299","owner_name":"O'Neill Julie","owner_display_name":"O'Neill Julie","owner_url":"/insider/0001630299","role":"Officer (EVP. Global Operations)","role_mark":"O","role_mark_label":"Officer (EVP. Global Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP. Global Operations","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":778.0,"shares_display":"778","price_per_share":138.0711439588689,"price_display":"138.07","price_state":"stated","total_value":107419.35,"total_display":"107,419.35","total_whole":"107,419","shares_owned_after":30348.0,"shares_owned_after_display":"30,348","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-08","filed_date":"2016-02-08","scope":"insider","n_lines":2},{"id":2235617,"accession":"0000899866-16-000238","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899866-16-000238","line_url":"/filing/0000899866-16-000238","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001630299","owner_name":"O'Neill Julie","owner_display_name":"O'Neill Julie","owner_url":"/insider/0001630299","role":"Officer (EVP. Global Operations)","role_mark":"O","role_mark_label":"Officer (EVP. Global Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP. Global Operations","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2080.0,"shares_display":"2,080","price_per_share":143.23042788461538,"price_display":"143.23","price_state":"stated","total_value":297919.29,"total_display":"297,919.29","total_whole":"297,919","shares_owned_after":31126.0,"shares_owned_after_display":"31,126","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-05","filed_date":"2016-02-08","scope":"insider","n_lines":5},{"id":8856114,"accession":"0000899866-15-000176","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-15-000176","line_url":"/filing/0000899866-15-000176#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001630299","owner_name":"O'Neill Julie","owner_display_name":"O'Neill Julie","owner_url":"/insider/0001630299","role":"Officer (EVP. Global Operations)","role_mark":"O","role_mark_label":"Officer (EVP. Global Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP. Global Operations","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":647.0,"shares_display":"647","price_per_share":171.76,"price_display":"171.76","price_state":"stated","total_value":111128.72,"total_display":"111,128.72","total_whole":"111,129","shares_owned_after":21443.0,"shares_owned_after_display":"21,443","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-02","filed_date":"2015-09-10","scope":"insider"},{"id":8196644,"accession":"0000899866-15-000078","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899866-15-000078","line_url":"/filing/0000899866-15-000078#line-2","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001630299","owner_name":"O'Neill Julie","owner_display_name":"O'Neill Julie","owner_url":"/insider/0001630299","role":"Officer (EVP. Global Operations)","role_mark":"O","role_mark_label":"Officer (EVP. Global Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP. Global Operations","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6565.0,"shares_display":"6,565","price_per_share":180.34,"price_display":"180.34","price_state":"stated","total_value":1183932.1,"total_display":"1,183,932.10","total_whole":"1,183,932","shares_owned_after":22090.0,"shares_owned_after_display":"22,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-02","filed_date":"2015-03-03","scope":"insider"},{"id":8196643,"accession":"0000899866-15-000078","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-15-000078","line_url":"/filing/0000899866-15-000078#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001630299","owner_name":"O'Neill Julie","owner_display_name":"O'Neill Julie","owner_url":"/insider/0001630299","role":"Officer (EVP. Global Operations)","role_mark":"O","role_mark_label":"Officer (EVP. Global Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP. Global Operations","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5100.0,"shares_display":"5,100","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":28655.0,"shares_owned_after_display":"28,655","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-27","filed_date":"2015-03-03","scope":"insider"},{"id":8170685,"accession":"0000899866-15-000054","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-15-000054","line_url":"/filing/0000899866-15-000054#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001630299","owner_name":"O'Neill Julie","owner_display_name":"O'Neill Julie","owner_url":"/insider/0001630299","role":"Officer (EVP. Global Operations)","role_mark":"O","role_mark_label":"Officer (EVP. Global Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP. Global Operations","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":795.0,"shares_display":"795","price_per_share":171.15,"price_display":"171.15","price_state":"stated","total_value":136064.25,"total_display":"136,064.25","total_whole":"136,064","shares_owned_after":23555.0,"shares_owned_after_display":"23,555","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-10","filed_date":"2015-02-12","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":32,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":32,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":32},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001060955","name":"ICON PLC","url":"/issuer/0001060955","role":"Director","n_filings":1,"first_seen":"2026-08-12","last_seen":"2026-08-12"},{"type":"issuer","type_label":"ISSUER","cik":"0000899866","name":"ALEXION PHARMACEUTICALS INC","url":"/issuer/0000899866","role":"Officer (EVP. Global Operations)","n_filings":15,"first_seen":"2015-02-12","last_seen":"2018-03-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001630299","retrieved_at":"2026-08-22T15:08:10+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}